Journal of Anesthesia

, Volume 9, Issue 1, pp 103–105 | Cite as

Perioperative measurements of IL-6 and α-melanocyte stimulating hormone in a cardiac transplant patient after ventricular assist device support

  • Tetsuhiro Sakai
  • Akira Kudoh
  • Naoki Kotani
  • Terry W. Latson
  • Adolf H. Giesecke
  • Akitomo Matsuki
Clinical Reports

Key words

Interleukin-6 α-MSH Ventricular assist device Transplantation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McBride LR, Ruzevich SA, Pennington DG (1987) Infectious complications associated with ventricular assist device support. Trans AM Soc Artif Intern Organs 33:201–202Google Scholar
  2. 2.
    Cruickshank AM, Fraser WD, Burns HJG (1990) Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. clin Sci 79:161–165PubMedGoogle Scholar
  3. 3.
    Marinkovic S, Jahreis GP, Wong GG (1989) IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 142:808–812PubMedGoogle Scholar
  4. 4.
    Lipton JM (1989) Modulation of Host Defense by the Neuropeptide a-MSH. Yale J Biol Med 63:173–182Google Scholar
  5. 5.
    Lipton JM (1989) Neuropeptide α-Melanocyte-Stimulating Hormone in Control of Fever, the Acute Phase Response, and Inflammation. Neuroimmune Networks: Physiology and Diseases 243–250Google Scholar
  6. 6.
    Catania A, Lipton JM (to be published) α-MSH: Its Actions in Host response and Relationships with the hypothalamic-Pituitary-Adrenal Axis. Immune-Neuro-Endocrine NeworksGoogle Scholar
  7. 7.
    Wong GW, Clark SC (1988) Multiple actions of interleukin 6 within a cytokine network. Immunol Today 9:137–139PubMedCrossRefGoogle Scholar
  8. 8.
    Kohase M, Henriksen-DeStefano D (1986) May LT: Induction ofβ 2-Interferon by Tumor Necrosis Factor: A Homeostatic Mechanism in the Control of Cell Proliferation. Cell 45:659–666PubMedCrossRefGoogle Scholar
  9. 9.
    Nijsten MWN, Groot ER, Tenduis HJ (1987) Serum Levels of Interleukin-6 and Acute Phase Responses. Lancet 17:921CrossRefGoogle Scholar
  10. 10.
    Van Oers MHJ, Van Der Heyden Aapam, Aarden LA (1988) Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 71:314–219PubMedGoogle Scholar
  11. 11.
    Sakai T, Latson TW, Giesecke AH (1993) Periopeative changes in IL-6 with cardiac transplantation. J Cardiothoracic Anesth 17: 17–22CrossRefGoogle Scholar
  12. 12.
    Shenkin A, Fraser WD, Series J (1989) The Serum Interleukin 6 Response to Elective Surgery. Lymphokine Res 8:123–127PubMedGoogle Scholar
  13. 13.
    Termuhlen DF, Pennington DG, Roodman ST (1989) T cells in Ventricular Assist Device Patients. Circulation 80:III-174–III-182Google Scholar
  14. 14.
    Ide H, Kakiuchi T, Furuta N (1987) The effect of cardiopulmonary bypass on T-cells and their subpopulations. Ann Thorac Surg 44:277–282PubMedCrossRefGoogle Scholar
  15. 15.
    Gascon P, Zoumbos NC, Young NS (1984) Immunologic abnormalities in patients receiving multiple blood transfusions Ann Intern Med 100:173–177PubMedGoogle Scholar
  16. 16.
    Stelzer GT, Ward RA, Wellhausen SR (1987) Alterations in Select Immunologic Parameters Following Total Artificial Heart Implantation. Artificial Organs 11:52–62PubMedCrossRefGoogle Scholar
  17. 17.
    Fauci AS, Dale DC (1975) The effect of hydrocortisone on the kinetics of normal human lymphocytes. Blood 46:235–243PubMedGoogle Scholar
  18. 18.
    Brody JI, Pickering NJ, Fink GB (1987) Altered Lymphocyte Subsets During Cardiopulmonary Bypass. Am J Clin Pathol 87:626–628PubMedGoogle Scholar

Copyright information

© JSA 1995

Authors and Affiliations

  • Tetsuhiro Sakai
    • 1
  • Akira Kudoh
    • 1
  • Naoki Kotani
    • 1
  • Terry W. Latson
    • 2
  • Adolf H. Giesecke
    • 2
  • Akitomo Matsuki
    • 1
  1. 1.Department of AnesthesiologyHirosaki University School of MedicineHirosakiJapan
  2. 2.Department of AnesthesiologyThe University of Texas, Southwestern Medical CenterDallasUSA

Personalised recommendations